All the news Showing 10 of 63 articles from: FranceGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Treatment for people who use drugs Peer-led recruitment improves hepatitis C screening in people who use drugs Keith Alcorn / 25 July 2022 A peer-led recruitment strategy proved highly successful in engaging people who use drugs in testing and treatment for hepatitis C in the French city of Montpellier, researchers from the University of Montpellier report ... Life after the cure People cured of hepatitis C remain at higher risk of death due to liver- and drug-related causes Keith Alcorn / 24 June 2022 People who have been cured of hepatitis C remain at higher risk of dying from liver-related causes than the general population, but their risk of cardiovascular events goes down after being cured, ... Life after the cure People with diabetes or heavy alcohol consumption at higher risk of severe fibrosis after hepatitis C cure Keith Alcorn / 18 May 2022 People with diabetes or high alcohol intake after hepatitis C cure are less likely to experience reductions in liver fibrosis after hepatitis C cure and remained at higher risk of severe liver ... Mother to child Immunoglobulin-free strategy highly effective for prevention of mother-to-child hepatitis B transmission in Cambodia Keith Alcorn / 22 February 2022 A hepatitis B immunuglobulin-free strategy for prevention of mother-to-child hepatitis B transmission is feasible and highly effective in a resource-limited setting if tenofovir is given for at least four weeks prior to delivery, ... Transmission, epidemiology and prevention New cases of hepatitis C declining in people with HIV as access to treatment broadens Keith Alcorn / 21 February 2022 The availability of direct-acting antivirals has led to a 50% reduction in new cases of hepatitis among people with HIV in some high-income settings, a six-country study presented this week ... Hepatitis delta Bulevirtide for hepatitis D proves effective in real-world studies Liz Highleyman / 25 January 2022 The entry inhibitor bulevirtide (Hepcludex) led to a reduction in hepatitis delta virus (HDV) viral load and improved liver enzyme levels in real-world studies in France and Austria, according to findings presented ... Sexual transmission New cases of hepatitis C have fallen among gay and bisexual men with HIV in France Keith Alcorn / 22 October 2021 The rate of new hepatitis C infections halved among gay and bisexual men with HIV in France between 2014 and 2017 following the introduction of direct-acting antivirals, a French cohort study has ... Screening and testing policy People with diabetes or high alcohol consumption at higher risk of late hepatitis C diagnosis Keith Alcorn / 24 September 2021 People with diabetes and those with hazardous alcohol intake were significantly more likely to remain undiagnosed with hepatitis C and present with advanced fibrosis, a large number of people diagnosed with hepatitis ... Coronavirus US CDC recommends third dose of Moderna or Pfizer COVID-19 vaccines for organ transplant recipients Keith Alcorn / 16 August 2021 People who have undergone a solid organ transplant and who received the Pfizer or Moderna COVID-19 vaccines should receive a third dose, the US Centers for Disease Control and Prevention (CDC) recommended ... Coronavirus Advanced cirrhosis or alcohol use disorder raised the risk of COVID-19 death in France Keith Alcorn / 25 June 2021 People with advanced cirrhosis or alcohol use disorder were significantly more likely to die from COVID-19 in France during 2020 compared to the rest of the population, a study of the French ... ← First12345...7Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive